In tumor cells, P-gp substrates include chemotherapeutic agents such as doxorubicin, etoposide, and trichostatin A. Thyroid hormone is known to stimulate expression of the MDR1 gene and activity of P-gp and thus may be seen to support chemoresistance. Here, PGP is linked to neoplasm.